These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 2940720

  • 1. [Evaluation of the specific action of sorbents used in clinical practice with immobilized house dust allergen].
    Lebedin IuS, Zimin IuI, Kapitonova ME.
    Ter Arkh; 1986; 58(4):31-4. PubMed ID: 2940720
    [No Abstract] [Full Text] [Related]

  • 2. [Extracorporeal immunosorption in the treatment of atopic bronchial asthma].
    Mavraev DE.
    Ter Arkh; 1986; 58(4):29-30. PubMed ID: 2940719
    [Abstract] [Full Text] [Related]

  • 3. [Extracorporeal specific immunosorption in the complex treatment of patients with bronchial asthma and hypersensitivity to house dust allergen].
    Chuchalin AG, Raudla LA, Tatarskiĭ AR, Shurkalin BK, Evseev NG.
    Ter Arkh; 1984; 56(6):24-8. PubMed ID: 6474372
    [No Abstract] [Full Text] [Related]

  • 4. [Extracorporeal immunocorrection].
    Lopukhin IuM, Kulaev DV, Koval'chuk LV.
    Klin Med (Mosk); 1986 Mar; 64(3):11-7. PubMed ID: 2940414
    [No Abstract] [Full Text] [Related]

  • 5. [Extracorporeal immunosorption].
    Lopukhin IuM, Kulaev DV.
    Ter Arkh; 1985 Mar; 57(10):65-71. PubMed ID: 2934846
    [No Abstract] [Full Text] [Related]

  • 6. IgE-facilitated antigen presentation: role in allergy and the influence of allergen immunotherapy.
    Wilcock LK, Francis JN, Durham SR.
    Immunol Allergy Clin North Am; 2006 May; 26(2):333-47, viii-ix. PubMed ID: 16701148
    [Abstract] [Full Text] [Related]

  • 7. [The value of immunotherapy in treatment of IgE-induced allergic diseases].
    Müller UR.
    Ther Umsch; 1994 Jan; 51(1):67-76. PubMed ID: 7511841
    [Abstract] [Full Text] [Related]

  • 8. [New concepts in therapy of type I allergic diseases].
    Valenta R, Steinberger P, Vrtala S, Grote M, Laffer S, Sperr WR, Valent P, Kraft D, Scheiner O.
    Wien Klin Wochenschr; 1993 Jan; 105(23):682-6. PubMed ID: 7508663
    [Abstract] [Full Text] [Related]

  • 9. Novel ways for immune intervention in immunotherapy: mucosal allergy vaccines.
    Mascarell L, Van Overtvelt L, Moingeon P.
    Immunol Allergy Clin North Am; 2006 May; 26(2):283-306, vii-viii. PubMed ID: 16701145
    [Abstract] [Full Text] [Related]

  • 10. Component-resolved diagnosis of house-dust mite allergy with purified natural and recombinant mite allergens.
    Pittner G, Vrtala S, Thomas WR, Weghofer M, Kundi M, Horak F, Kraft D, Valenta R.
    Clin Exp Allergy; 2004 Apr; 34(4):597-603. PubMed ID: 15080813
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Allergen-related approaches to immunotherapy.
    Rolland JM, Gardner LM, O'Hehir RE.
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [Abstract] [Full Text] [Related]

  • 13. [Immunosorption in the treatment of an atopic form of bronchial asthma].
    Chuchalin AG, Shurkalin BK, Evseev NG, Strelko VV, Sukharenko NV.
    Sov Med; 1984 Mar; (8):34-6. PubMed ID: 6238418
    [No Abstract] [Full Text] [Related]

  • 14. [Immunological mechanisms in allergen-specific immunotherapy: impact on future trends in type-1 allergy management].
    Ebner C.
    Wien Med Wochenschr; 1999 Mar; 149(14-15):438-41. PubMed ID: 10584289
    [Abstract] [Full Text] [Related]

  • 15. Immunological mechanisms of allergen-specific immunotherapy.
    Larché M, Akdis CA, Valenta R.
    Nat Rev Immunol; 2006 Oct; 6(10):761-71. PubMed ID: 16998509
    [Abstract] [Full Text] [Related]

  • 16. [Desensitization, hyposensitization, specific immunotherapy].
    Forzy ML.
    Allerg Immunol (Paris); 1996 Jan; 28(1):7-18. PubMed ID: 8882206
    [Abstract] [Full Text] [Related]

  • 17. [Hyposensitization in general practice. A strategic concept].
    Jorde W.
    HNO; 1995 Dec; 43(12):741-4. PubMed ID: 8582837
    [No Abstract] [Full Text] [Related]

  • 18. Engineering of the major house dust mite allergen Der f 2 for allergen-specific immunotherapy.
    Takai T, Yokota T, Yasue M, Nishiyama C, Yuuki T, Mori A, Okudaira H, Okumura Y.
    Nat Biotechnol; 1997 Aug; 15(8):754-8. PubMed ID: 9255789
    [Abstract] [Full Text] [Related]

  • 19. [The immunological background of the allergen vaccines application].
    Rogala B.
    Wiad Lek; 1999 Aug; 52(11-12):539-46. PubMed ID: 10745688
    [Abstract] [Full Text] [Related]

  • 20. Adverse effects and fatalities associated with subcutaneous allergen immunotherapy.
    Bukantz SC, Bagg AS, Lockey RF.
    Clin Allergy Immunol; 2008 Aug; 21():455-68. PubMed ID: 18828523
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.